![](/img/cover-not-exists.png)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Bigal, Marcelo E, Edvinsson, Lars, Rapoport, Alan M, Lipton, Richard B, Spierings, Egilius L H, Diener, Hans-Christoph, Burstein, Rami, Loupe, Pippa S, Ma, Yuju, Yang, Ronghua, Silberstein, Stephen DLanguage:
english
Journal:
The Lancet Neurology
DOI:
10.1016/S1474-4422(15)00245-8
Date:
September, 2015
File:
PDF, 296 KB
english, 2015